Man she can't catch a break LOL
World Anti-Doping Agency (WADA) and International Association of Athletics Federations (IAAF) v. United States Anti-Doping Agency (USADA) and Lindsey Scherf, CAS 2007/A/1416. Lindsey Scherf was diagnosed with exercise induced asthma in 2003. She applied for, and was given, an Abbreviated Therapeutic Use Exemption (ATUE) from the IAAF for her asthma medication, Flovent, in 2005 and from USADA in 2006 and 2007. Scherf wanted to participate in the Gold Coast Marathon in July 2007 in Australia. Prior to the race USADA informed her that she would need an ATUE from the IAAF, and that they would forward her application. Scherf did not hear whether her application was granted, and she was not in a position to stop using her medication, therefore, she attempted to find out if there would be drug testing at the marathon. She was told that there likely would not be any drug testing, as there had not been the past three years, so Scherf participated in the marathon. After the race she was selected for drug testing, but she refused to take the test knowing she would test positively. The next day Scherf requested to be tested, but it was too late. As it turned out, Scherf did not need this separate ATUE that USADA had informed her she needed. USADA offered Scherf a reduced one year suspension but WADA and the IAAF felt the full two year suspension was more appropriate. Because of the mistakes made by USADA and the IAAF, CAS determined that exceptional circumstances did exist in this case and thus Scherf bears no significant fault or negligence. Therefore, the one year suspension was sufficient.